VLIARO
LIVE

Serial Number

79184522

Owner

Novartis AG

Filing Date

Jan 18, 2016

Add to watchlist:

No watchlists yet
View on USPTO

VLIARO Trademark

Serial Number: 79184522 • Registration: 5010375

VLIARO is a trademark filed by Novartis AG on January 18, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

January 18, 2016

Registration Date

August 2, 2016

Published for Opposition

May 17, 2016

Cancellation Date

July 1, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Feb 12, 2026 DETH
DEATH OF INTERNATIONAL REGISTRATION
Jan 22, 2026 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Nov 12, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 25, 2023 INTS
INVALIDATION PROCESSED
Oct 25, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 17, 2023 INTR
CANCELLED SECTION 71
Feb 17, 2023 C71T
NOTIFICATION PROCESSED BY IB
Sep 23, 2016 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 2, 2016 FICS
FINAL DISPOSITION PROCESSED
Sep 2, 2016 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Sep 1, 2016 GPAR
REGISTERED-PRINCIPAL REGISTER
Aug 2, 2016 R.PR
PUBLISHED FOR OPPOSITION
May 17, 2016 PUBO
NOTICE OF PUBLICATION
Apr 27, 2016 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2016 CNSA
ASSIGNED TO EXAMINER
Apr 5, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 18, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 11, 2016 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 10, 2016 SDRC